Celldex Therapeutics Inc (CLDX)
37.02
-0.75
(-1.99%)
USD |
NASDAQ |
Apr 24, 16:00
37.01
-0.01
(-0.03%)
After-Hours: 20:00
Celldex Therapeutics Cash from Operations (Quarterly): -32.53M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -32.53M |
| September 30, 2023 | -18.99M |
| June 30, 2023 | -27.20M |
| March 31, 2023 | -28.57M |
| December 31, 2022 | -21.76M |
| September 30, 2022 | -35.19M |
| June 30, 2022 | -22.24M |
| March 31, 2022 | -24.53M |
| December 31, 2021 | -14.52M |
| September 30, 2021 | -16.37M |
| June 30, 2021 | -11.93M |
| March 31, 2021 | -18.08M |
| December 31, 2020 | -5.211M |
| September 30, 2020 | -11.86M |
| June 30, 2020 | -11.22M |
| March 31, 2020 | -12.11M |
| December 31, 2019 | -11.00M |
| September 30, 2019 | -11.14M |
| June 30, 2019 | -11.04M |
| March 31, 2019 | -13.23M |
| December 31, 2018 | -15.43M |
| September 30, 2018 | -14.39M |
| June 30, 2018 | -17.40M |
| March 31, 2018 | -28.02M |
| December 31, 2017 | -19.52M |
| Date | Value |
|---|---|
| September 30, 2017 | -24.36M |
| June 30, 2017 | -20.79M |
| March 31, 2017 | -35.26M |
| December 31, 2016 | -20.35M |
| September 30, 2016 | -23.96M |
| June 30, 2016 | -33.83M |
| March 31, 2016 | -34.90M |
| December 31, 2015 | -13.74M |
| September 30, 2015 | -27.79M |
| June 30, 2015 | -24.76M |
| March 31, 2015 | -32.59M |
| December 31, 2014 | -22.21M |
| September 30, 2014 | -26.59M |
| June 30, 2014 | -20.86M |
| March 31, 2014 | -31.88M |
| December 31, 2013 | -14.96M |
| September 30, 2013 | -17.45M |
| June 30, 2013 | -18.06M |
| March 31, 2013 | -17.20M |
| December 31, 2012 | -13.33M |
| September 30, 2012 | -10.94M |
| June 30, 2012 | -11.96M |
| March 31, 2012 | -13.55M |
| December 31, 2011 | -9.37M |
| September 30, 2011 | -8.059M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-35.19M
Minimum
Sep 2022
-5.211M
Maximum
Dec 2020
-18.19M
Average
-16.37M
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
| ThermoGenesis Holdings Inc | -2.043M |
| Perspective Therapeutics Inc | -9.008M |
| Electromed Inc | 3.471M |
| Xtant Medical Holdings Inc | -0.915M |
| Asensus Surgical Inc | -13.37M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -171.16M |
| Cash from Financing (Quarterly) | 217.37M |
| Free Cash Flow | -109.11M |
| Free Cash Flow Per Share (Quarterly) | -0.6376 |
| Free Cash Flow to Equity (Quarterly) | -33.20M |
| Free Cash Flow Yield | -6.08% |